Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
There is no evidence in current databases or peer-reviewed literature to support the existence of a molecule called "CYRIB antisense RNA 1" (CYRIB-AS1). The gene CYRIB (CYFIP Related Rac1 Interactor B) is a known protein-coding gene involved in actin regulation and cell signaling[1], but there are no documented antisense RNAs, circular RNAs, or related non-coding transcripts annotated specifically as "CYRIB-AS1." This may be a misnomer, a misinterpretation, or a not yet-characterized transcript. Context and evaluation: - CYRIB is a protein-coding gene and participates in cytoskeletal organization and innate immunity[1]. - Antisense RNAs, especially non-coding or circular RNA forms, are noted in other genes (such as SCRIB[2]), but not for CYRIB. - No sources retrieved reference a CYRIB antisense RNA or "CYRIB-AS1" as either a gene, RNA, or therapeutic target[1][2][3]. If you have additional context (database IDs, other species, or synonyms), that might help clarify if a lesser-known or newly characterized transcript is intended. As it stands, CYRIB antisense RNA 1 (CYRIB-AS1) does not correspond to a recognized molecular entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CYRIB antisense RNA 1 (CYRIB-AS1).